About Scioderm, Inc.
Scioderm is a biopharmaceutical company focused on developing innovative therapies for treating diseases with high unmet need, including orphan products. Our lead product, SD-101, is being developed for treatment of the skin effects associated with Epidermolysis Bullosa (EB), which is a rare genetic connective tissue disorder. There are many genetic and symptomatic variations of EB, but all share the prominent symptom of extremely fragile skin that blisters and tears from minor friction or trauma. Internal organs and bodily systems can also be seriously affected by the disease. Specialties Epidermolysis Bullosa (EB)
Scioderm, Inc. Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location
X